Using genomics in medicine

What if every newborn received a genome sequence alongside the traditional heel prick test? The Economist explores the rapid expansion of genomic newborn screening through England’s Generation Study, BabySeq in the United States, and similar efforts across Australia and Europe, highlighting both the potential to transform early diagnosis and the ethical challenges that accompany its … Continued

Drawing on emerging research in newborn genomic screening, including studies led by Dr. Robert Green, this Opinion piece examines both the promise and complexity of using genome sequencing in newborn care. Daniela Lamas examines questions about uncertainty, parental decision-making, and the future of genomic newborn screening as large-scale studies begin enrolling tens of thousands of … Continued

In celebration of 2026 Rare Disease Day, nearly 2,300 researchers, clinicians, patients, and advocates filled the halls of the NIH Natcher Conference Center or joined virtually to highlight the urgency and opportunity of advancing rare disease research. With more than 10,000 identified rare diseases affecting millions of Americans, speakers emphasized the need for innovative trial … Continued

APHL celebrates the launch of BEACONS, the nation’s first multi-state initiative evaluating whether whole genome sequencing (WGS) can be responsibly integrated into the U.S. newborn screening system. With a $14.4M NIH award and invaluable participation from public health labs across the country, BEACONS will test how WGS affects workflows, consent, data systems, and the actionable … Continued